About 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one
2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one (PubChem CID 166118916) has the molecular formula C30H28F3N7O2
and a molecular weight of 575.60 g/mol. Its IUPAC name is 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one.
Molecular Properties
| Compound Name | 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one |
| PubChem CID | 166118916 |
| Molecular Formula | C30H28F3N7O2 |
| Molecular Weight | 575.60 g/mol |
| Exact Mass | 575.23 |
| IUPAC Name | 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one |
| SMILES | CCc1cc(OC)c2nncc(N3CCc4c(cc(Cn5ccnc5C)cc4-c4cn(C)nc4C(F)(F)F)C3=O)c2c1 |
| InChI | InChI=1S/C30H28F3N7O2/c1-5-18-10-23-25(14-35-36-27(23)26(13-18)42-4)40-8-6-20-21(24-16-38(3)37-28(24)30(31,32)33)11-19(12-22(20)29(40)41)15-39-9-7-34-17(39)2/h7,9-14,16H,5-6,8,15H2,1-4H3 |
| InChIKey | BPULWIXGTDKIFH-UHFFFAOYSA-N |
| XLogP | 5.38 |
| TPSA | 90.96 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 575.60 |
| LogP ≤ 5 | 5.38 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one?
The IUPAC name of 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one (CID 166118916) is 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one.
What is the SMILES notation for 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one?
The canonical SMILES for 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one is CCc1cc(OC)c2nncc(N3CCc4c(cc(Cn5ccnc5C)cc4-c4cn(C)nc4C(F)(F)F)C3=O)c2c1.
What is the InChIKey of 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one?
The InChIKey is BPULWIXGTDKIFH-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H28F3N7O2/c1-5-18-10-23-25(14-35-36-27(23)26(13-18)42-4)40-8-6-20-21(24-16-38(3)37-28(24)30(31,32)33)11-19(12-22(20)29(40)41)15-39-9-7-34-17(39)2/h7,9-14,16H,5-6,8,15H2,1-4H3.
What are the key properties of 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one?
2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one has a molecular weight of 575.60 g/mol, XLogP of 5.38, 6 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(6-ethyl-8-methoxycinnolin-4-yl)-7-[(2-methylimidazol-1-yl)methyl]-5-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-3,4-dihydroisoquinolin-1-one is sourced from PubChem (CID 166118916), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).